• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们别再讨论“柠檬酸盐毒性”了。

Let's stop talking about 'citrate toxicity'.

机构信息

Nephrology Division, NYU Grossman School of Medicine and Nephrology Section, NY Harbor VA Healthcare System, New York, New York, USA.

出版信息

Curr Opin Nephrol Hypertens. 2024 Mar 1;33(2):181-185. doi: 10.1097/MNH.0000000000000953. Epub 2023 Nov 14.

DOI:10.1097/MNH.0000000000000953
PMID:37962170
Abstract

PURPOSE OF REVIEW

Continuous renal replacement therapy (CRRT) is a vital medical intervention used in critically ill patients with acute kidney injury (AKI). One of the key components of adequate clearance with CRRT is the use of anticoagulants to prevent clotting of the extracorporeal circuit. Regional citrate anticoagulation is the most often recommended modality. The term 'citrate toxicity' is used to describe potential adverse effects of accumulation of citrate and subsequent hypocalcemia. However, citrate is itself not inherently toxic. The term and diagnosis of citrate toxicity are questioned in this review.

RECENT FINDINGS

Citrate is being increasingly used for regional anticoagulation of the CRRT circuit. Citrate accumulation is infrequent and can cause hypocalcemia and metabolic alkalosis, which are potential adverse effects. Citrate itself, however, is not a toxic molecule. The term 'citrate toxicity' has been used to denote hypocalcemia and metabolic acidosis. However, citrate administration is well known to cause systemic and urinary alkalinization and under certain circumstances, metabolic alkalosis, but is not associated itself with any 'toxic' effects.We review the existing literature and debunk the perceived toxicity of citrate. We delve into the metabolism and clearance of citrate and question current data suggesting metabolic acidosis occurs as the result of citrate accumulation.

SUMMARY

In conclusion, this article calls into question prevailing concerns about 'citrate toxicity'. We emphasize the need for a more nuanced understanding of its safety profile. We recommend discarding the term 'citrate toxicity' in favor of another frequently used, but more meaningful term: 'citrate accumulation'.

摘要

目的综述

连续肾脏替代疗法(CRRT)是治疗急性肾损伤(AKI)危重症患者的重要医疗手段。CRRT 充分清除的关键之一是使用抗凝剂预防体外回路凝血。局部枸橼酸抗凝是最常推荐的方法。“枸橼酸盐毒性”一词用于描述枸橼酸盐蓄积和随后低钙血症的潜在不良反应。然而,枸橼酸盐本身并不具有毒性。本文对枸橼酸盐毒性的术语和诊断提出了质疑。

最新发现

枸橼酸盐越来越多地用于 CRRT 回路的局部抗凝。枸橼酸盐蓄积不常见,但可引起低钙血症和代谢性碱中毒,这是潜在的不良反应。然而,枸橼酸盐本身并不是有毒分子。“枸橼酸盐毒性”一词用来表示低钙血症和代谢性酸中毒。然而,枸橼酸盐的使用众所周知会导致全身和尿碱化,在某些情况下会导致代谢性碱中毒,但本身与任何“毒性”作用无关。我们回顾了现有的文献,驳斥了枸橼酸盐被认为具有毒性的观点。我们深入研究了枸橼酸盐的代谢和清除,并对目前认为代谢性酸中毒是由于枸橼酸盐蓄积引起的数据提出了质疑。

总结

综上所述,本文对普遍存在的关于“枸橼酸盐毒性”的担忧提出了质疑。我们强调需要更细致地了解其安全性特征。我们建议摒弃“枸橼酸盐毒性”这一术语,转而使用另一个常用但更有意义的术语:“枸橼酸盐蓄积”。

相似文献

1
Let's stop talking about 'citrate toxicity'.我们别再讨论“柠檬酸盐毒性”了。
Curr Opin Nephrol Hypertens. 2024 Mar 1;33(2):181-185. doi: 10.1097/MNH.0000000000000953. Epub 2023 Nov 14.
2
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
3
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.区域枸橼酸抗凝与肝素抗凝用于连续性肾脏替代治疗的荟萃分析:随机对照试验的荟萃分析。
Am J Kidney Dis. 2012 Jun;59(6):810-8. doi: 10.1053/j.ajkd.2011.11.030. Epub 2012 Jan 5.
4
Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy.危重症患者连续性肾脏替代治疗中局部枸橼酸抗凝的疗效和安全性。
Intensive Care Med. 2012 Jan;38(1):20-8. doi: 10.1007/s00134-011-2438-3. Epub 2011 Nov 29.
5
Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.危重症患者连续性肾脏替代治疗的抗凝选择:系统评价和网络荟萃分析的随机对照试验。
Crit Care. 2023 Jun 7;27(1):222. doi: 10.1186/s13054-023-04519-1.
6
Development and Validation of a Risk Prediction Model for Citrate Accumulation in Patients Undergoing Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation.接受局部枸橼酸抗凝持续肾脏替代治疗患者枸橼酸蓄积风险预测模型的开发与验证
Blood Purif. 2025;54(4-5):250-263. doi: 10.1159/000545291. Epub 2025 Mar 20.
7
Diluted Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Pediatric Patients: A Systematic Review and Suggested Practice Points.小儿患者连续性肾脏替代治疗中稀释性局部枸橼酸盐抗凝:一项系统评价及推荐的实践要点
Blood Purif. 2025 Apr 21:1-19. doi: 10.1159/000545674.
8
Intervention measures to improve the filter life of continuous renal replacement therapy in critically ill patients-A systematic review.改善危重症患者连续性肾脏替代治疗滤器使用寿命的干预措施——一项系统评价
Nurs Crit Care. 2025 Jul;30(4):e13225. doi: 10.1111/nicc.13225. Epub 2024 Dec 9.
9
Evaluation of anticoagulant methods in newborns undergoing continuous renal replacement therapy: what is the optimum method?接受持续肾脏替代治疗的新生儿抗凝方法评估:最佳方法是什么?
Eur J Pediatr. 2025 Jul 9;184(8):473. doi: 10.1007/s00431-025-06314-2.
10
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.

引用本文的文献

1
Standard vs. carbone dioxide adapted kidney replacement therapy in hypercapnic ARDS patients: a randomized controlled pilot trial (BigBIC).标准与碳酸适应型肾脏替代治疗在高碳酸血症性 ARDS 患者中的比较:一项随机对照试验(BigBIC)。
Crit Care. 2024 Jun 11;28(1):198. doi: 10.1186/s13054-024-04979-z.